Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Clinical Transplantation|December 10, 2019
Biomarker discovery in cardiac allograft vasculopathy using targeted aptamer proteomicsAws Almufleh, Liyong Zhang, Lisa M Mielniczuk, et al.
BMC Health Services Research|August 30, 2012
How much are we spending? The estimation of research expenditures on cardiovascular disease in CanadaClaire de Oliveira, Van Hai Nguyen, Harindra C Wijeysundera, et al.
Circulation|March 19, 2008
Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarctionNorbert Degousee, Shafie Fazel, Denis Angoulvant, et al.
Circulation. Heart Failure|October 8, 2009
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarctionZamaneh Kassiri, Jiuchang Zhong, Danny Guo, et al.
The Journal of Clinical Investigation|June 19, 2002
Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditisMary Anne Opavsky, Tami Martino, Marlene Rabinovitch, et al.
European Heart Journal|April 28, 2020
Omics phenotyping in heart failure: the next frontierAntoni Bayes-Genis, Peter P Liu, David E Lanfear, et al.
The Canadian Journal of Cardiology|June 23, 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying MechanismsG B John Mancini, Jonathan G Howlett, Jeffrey Borer, et al.
CMAJ Open|August 1, 2014
Estimating the payoffs from cardiovascular disease research in Canada: an economic analysisClaire de Oliveira, Hai V Nguyen, Harindra C Wijeysundera, et al.
The Canadian Journal of Cardiology|December 11, 2012
Canada's contribution to global research in cardiovascular diseasesHai V Nguyen, Claire de Oliveira, Harindra C Wijeysundera, et al.
Pageof 18